Infusion Laboratory: Protocol 1 - Selegeline - 2

NCT00000337 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cocaine-Related Disorders

Interventions

DRUG: Selegiline

Sponsor

National Institute on Drug Abuse (NIDA)